X
Xenon Pharmaceuticals Inc
F:XP0
Xenon Pharmaceuticals Inc
F:XP0
Price:
58.5
EUR
-0.85%
Market Closed
Market Cap:
€4.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xenon Pharmaceuticals Inc
F:XP0
|
CA |
|
I
|
IAMGOLD Corp
XMUN:IAL
|
CA |
|
Pulmatrix Inc
F:2PU
|
US |
|
Paradigm Biopharmaceuticals Ltd
F:P86
|
AU |
|
Heidelberger Druckmaschinen AG
F:HDD
|
DE |
|
T
|
Technicolor Creative Studios SA
PAR:TCHCS
|
FR |
|
F
|
Funko Inc
F:FU2
|
US |
Wall St Price Targets
XP0 Price Targets Summary
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc
Wall Street analysts forecast XP0 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for XP0 is 48.7 EUR with a low forecast of 37.25 EUR and a high forecast of 61.47 EUR.
Lowest Forecast
Price Target
37.25
EUR
36% Downside
Average Forecast
Price Target
48.7
EUR
17% Downside
Highest Forecast
Price Target
61.47
EUR
5% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XP0's stock price target?
Price Target
48.7
EUR
48.7
EUR
According to Wall Street analysts, the average 1-year price target for XP0 is 48.7 EUR with a low forecast of 37.25 EUR and a high forecast of 61.47 EUR.
What is the Revenue forecast for Xenon Pharmaceuticals Inc?
Projected CAGR
108%
108%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 8 years is 108%.
